European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Reports 2024 Year-End Financial Results and Provides Business Update 27.03.2025 / 21:06 CET/CEST The issuer is solely responsible for the ...

We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...

Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...

NIH-supported researchers have developed a new method using a protein from tardigrades to help protect healthy tissue during cancer radiation therapy, showing early promise in lab tests.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

This study shows that RNA decay rather than the presence of premature termination codons triggers a TA-like response.

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...

The research field of 'cellular IRESes' lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated ...

The United States has undergone several changes in foreign and domestic policy since US President Donald Trump took office in January. Scientists who rely on federal grants for their work have been ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.